Prematurity; Extreme Clinical Trial
Official title:
Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm: A Randomized Trial
This is a masked randomized clinical trial in which extremely preterm infants fed human milk will be randomly assigned to receive either the highest (intervention group) or lowest (control group) vitamin D dose recommended during the first 14 days after birth.
Status | Recruiting |
Enrollment | 126 |
Est. completion date | December 2024 |
Est. primary completion date | October 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Day to 4 Days |
Eligibility | Inclusion Criteria: - Gestational age of 28 weeks or less Exclusion Criteria: - Major congenital anomalies and infants - Terminal illness in whom decisions to withhold or limit life support have been made |
Country | Name | City | State |
---|---|---|---|
United States | University of Alabama at Birmingham | Birmingham | Alabama |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Severity of respiratory morbidity | A scoring system that defines severity of respiratory morbidity based on the amount of ventilatory support and the need for supplemental oxygen | 0 - 120 days | |
Primary | Non-invasive oscillometry (NiOS) measurements of pulmonary mechanics | Using the tremoflo N-100 Neo Oscillometry device, we will determine the area under the reactance curve (AX) | 40 - 120 days | |
Secondary | Bronchopulmonary dysplasia | Number of participants receiving ventilatory support or supplemental oxygen at 36 weeks of postmenstrual age (PMA) or discharge | 36 weeks PMA or discharge |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03641209 -
Extremely Low Gestatonal Age Infants' Paracetamol Study
|
Phase 1/Phase 2 | |
Recruiting |
NCT04114435 -
Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
|
||
Completed |
NCT04639583 -
Use of NIRS in Preterm Population Born at Altitude
|
N/A | |
Recruiting |
NCT04294368 -
Targeted Fortification of Donor Breast Milk in Preterm Infants
|
N/A | |
Completed |
NCT03504215 -
Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health.
|
N/A | |
Recruiting |
NCT04735315 -
Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study
|
||
Completed |
NCT05684419 -
Preterm Infants Born to Homeless Mothers.
|
||
Recruiting |
NCT04270240 -
A NEW SCORING SYSTEM FOR PREDICTION OF PDA
|
||
Completed |
NCT04535375 -
Sonographic QUantification of Venous Circulation In the Preterm Brain
|
N/A | |
Recruiting |
NCT05280340 -
Anakinra for Preterm Infants Pilot
|
Phase 1/Phase 2 | |
Recruiting |
NCT05827250 -
Vibroacoustic Study of Lung Development in Newborn Infants
|
||
Recruiting |
NCT05824377 -
To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation.
|
N/A | |
Completed |
NCT03635944 -
Nutritional Care and Head Growth in Preterm Infants
|
||
Completed |
NCT03261609 -
Risk of Chronic Diseases in Young Adults Born Preterm: Relationship With Inflammation and Oxidative Stress Biomarkers.
|
||
Active, not recruiting |
NCT04325308 -
Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk
|
N/A | |
Active, not recruiting |
NCT04545866 -
The Budesonide in Babies (BiB) Trial
|
Phase 3 |